Alkoxymethylenephosphonate analogues of (Lyso)phosphatidic acid stimulate signaling networks coupled to the LPA2 receptor

ChemMedChem

Volumn 2, Issue 12, 2007, Pages 1789-1798

  Gajewiak, Joanna ^a   Tsukahara, Ryoko ^b   Tsukahara, Tamotsu ^b   Yu, Shuanxing ^c   Lu, Yiling ^c   Murph, Mandi ^c   Mills, Gordon B ^c   Tigyi, Gabor ^b   Prestwich, Glenn D ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF TENNESSEE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Agonists; GPCRs; Lysophosphatidic acid; Methylenephosphonates; Receptors

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; MASS SPECTROMETRY; METABOLISM; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; LYSOPHOSPHOLIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; NEOPLASMS; PHOSPHONIC ACIDS; RECEPTORS, LYSOPHOSPHATIDIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 48849087088     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200700111     Document Type: Article

References (60)

1. "The emerging role of lysophosphatidic acid in cancer": G. B. Mills, W. H. Moolenaar, Nat. Rev. Cancer 2003, 3, 582-591.
2. "Modulators of lysophosphatidic acid signaling": L. Feng, G. B. Mills, G. D. Prestwich, Expert Opin. Ther. Pat. 2003, 13, 1619-1634.
3. "A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross-talk with EGFR in prostate cancer cells": M. Bektas, S. G. Payne, H. Liu, S. Goparaju, S. Milstien, S. Spiegel, J. Cell Biol. 2005, 169(5), 801-811.
4. "Critical role of lysophospholipids in the pathophysiology, diagnosis, andmanag ement of ovarian cancer": G. B. Mills, A. Eder, X. Fang, Y. Hasegawa, M. Mao, Y. Lu, J. Tanyi, F. H. Tabassam, J. Wiener, R. Lapushin, S. Yu, J. A. Parrott, T. Compton, W. Tribley, D. Fishman, M. S. Stack, D. Gaudette, R. Jaffe, T. Furui, J. Aoki, J. R. Erickson, Cancer Treat. Res. 2002, 107, 259-283.
5. 3-mediated lysophosphatidic acid signalling in embryo implantation andspacing": X. Ye, K. Hama, J. J. Contos, B. Anliker, A. Inoue, M. K. Skinner, H. Suzuki, T. Amano, G. Kennedy, H. Arai, J. Aoki, J. Chun, Nature 2005, 435, 104-108.
6. "Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy": A. Tokumura, Y. Kanaya, M. Miyake, S. Yamano, M. Irahara, K. Fukuzawa, Biol. Reprod. 2002, 67(5), 1386-1392.
7. "Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second-messenger role for lysophosphatidic acid": S. P. Watson, R. T. McConnell, E. G. Lapetina, Biochem. J. 1985, 232(1), 61-66.
8. "Lysophosphatidic acid is a bioactive mediator in ovarian cancer": X. Fang, M. Schummer, M. Mao, S. Yu, F. H. Tabassam, R. Swaby, Y. Hasegawa, J. L. Tanyi, R. LaPushin, A. Eder, R. Jaffe, J. Erickson, G. B. Mills, Biochim. Biophys. Acta 2002, 1582(1-3), 257-264.
9. "Abnormal serum lysophospholipids in multiple myeloma patients": T. Sasagawa, M. Okita, J. Murakami, T. Kato, A. Watanabe, Lipids 1999, 34(1), 17-21.
10. "Bioactive lysophospholipids and their G protein-coupled receptors": W. H. Moolenaar, Exp. Cell Res. 1999, 253(1), 230-238.
11. "Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the EDG family": K. Noguchi, S. Ishii, T. Shimizu, J. Biol. Chem. 2003, 278(28), 25600- 25606.
12. "Lysophosphatidic acid binds to and activates GPR92, a G protein-coupledreceptor highly expressedin gastrointestinal lymphocytes": K. Kotarsky, A. Boketoft, J. Bristulf, N. E. Nilsson, A. Norberg, S. Hansson, R. Sillard, C. Owman, F. L. M. Leeb-Lundberg, B. Olde, J. Pharmacol. Exp. Ther. 2006, 318, 619-628.
13. 5": C.-W. Lee, R. Rivera, S. Gardell, A. Dubin, J. Chun, J. Biol. Chem. 2006, 281, 23589-23597.
14. "Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist": T. M. McIntyre, A. V. Pontsler, A. R. Silva, A. St. Hilaire, Y. Xu, J. C. Hinshaw, G. A. Zimmerman, K. Hama, J. Aoki, H. Arai, G. D. Prestwich, Proc. Natl. Acad. Sci. USA 2003, 100(1), 131-136.
15. "Molecular cloning andcharacte rization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid": K. Bandoh, J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi, K. Murakami-Murofushi, M. Tsujimoto, H. Arai, K. Inoue, J. Biol. Chem. 1999, 274, 27776-27785.
16. "Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activatedby LPA species. Structure-activity relationship of cloned LPA receptors": K. Bandoh, J. Aoki, A. Taira, M. Tsujimoto, H. Arai, K. Inoue, FEBS Lett. 2000, 478(1-2), 159 -165.
17. "Lipidphosph ate phosphatases regulate signal transduction through glycerolipids and sphingolipids": D. N. Brindley, D. English, C. Pilquil, K. Buri, Z. C. Ling, Biochim. Biophys. Acta 2002, 1582(1-3), 33-44.
18. "Are the curves in all the right places?": J. Zimmerberg, Traffic 2000, 1(4), 366-368.
19. "Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family": G. Tigyi, Mol. Pharmacol. 2001, 60(6), 1161-1164.
20. "Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells": Y. Fujiwara, V. Sardar, A. Tokumura, D. Baker, K. Murakami-Murofushi, A. Parrill, G. Tigyi, J. Biol. Chem. 2005, 280(41), 35038-35050.
21. "Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors": D. J. Fischer, N. Nusser, T. Virag, K. Yokoyama, D. A. Wang, D. L. Baker, D. Bautista, A. L. Parrill, G. Tigyi, Mol. Pharmacol. 2001, 60(4), 776-784.
22. 3 receptor": Y. Hasegawa, J. R. Erickson, G. J. Goddard, S. Yu, S. Liu, K. W. Cheng, A. Eder, K. Bandoh, J. Aoki, R. Jarosz, A. D. Schrier, K. R. Lynch, G. B. Mills, X. Fang, J. Biol. Chem. 2003, 278(14), 11 962-11969.
23. 3 receptor antagonist": C. E. Heise, W. L. Santos, A. M. Schreihofer, B. H. Heasley, Y. V. Mukhin, T. L. Macdonald, K. R. Lynch, Mol. Pharmacol. 2001, 60(6), 1173-1180.
24. "Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors": H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, M. Yagi, M. Sato, R. Suzuki, H. Murooka, T. Sakai, T. Nishitoba, D. S. Im, H. Nochi, K. Tamoto, H. Tomura, F. Okajima, Mol. Pharmacol. 2003, 64(4), 994-1005.
25. "Molecular mechanisms of lysophosphatidic acid action": G. Tigyi, A. L. Parrill, Prog. Lipid Res. 2003, 42(6), 498-526.
26. "New metabolically stabilizedanalogues of lysophosphatidic acid: Agonists, antagonists, andenzyme inhibitors": G. D. Prestwich, Y. Xu, L. Qian, J. Gajewiak, G. Jiang, Biochem. Soc. Trans. 2005, 33, 1357-1361.
27. "Synthesis of chiral (α,α-difluoroalkyl)phosphonate analogues of (lyso)-phosphatidic acid via hydrolytic kinetic resolution": Y. Xu, G. D. Prestwich, Org. Lett. 2002, 4(23), 4021-4024.
28. "Concise synthesis of acyl migration-blocked 1,1-difluorinated analogues of lysophosphatidic acid": Y. Xu, G. D. Prestwich, J. Org. Chem. 2002, 67(20), 7158-7161.
29. "Synthesis of monofluorinated analogues of lysophosphatidic acid": Y. Xu, L. Qian, G. D. Prestwich, J. Org. Chem. 2003, 68(13), 5320-5330.
30. "Synthesis of α-fluorinatedphosph onates from α-fluorovinylphosphonates: a new route to analogues of lysophosphatidic acid": Y. Xu, L. Qian, G. D. Prestwich, Org. Lett. 2003, 5(13), 2267-2270.
31. "Structure-activity relationships of fluorinated lysophosphatidic acid analogues": Y. Xu, J. Aoki, K. Shimizu, M. Umezu-Goto, K. Hama, Y. Takanezawa, S. Yu, G. B. Mills, H. Arai, L. Qian, G. D. Prestwich, J. Med. Chem. 2005, 48(9), 3319-3327.
32. 3 receptor-selective agonist activity": L. Qian, Y. Xu, Y. Hasegawa, J. Aoki, G. B. Mills, G. D. Prestwich, J. Med. Chem. 2003, 46, 5575-5578.
33. "Synthesis of novel alkyl thiophosphate LPA analogues as potential antagonists andagonists for lysophosphatidic acid (LPA) receptors": L. Qian, Y. Xu, T. D. Simper, G. Jiang, J. Aoki, M. Umezu-Goto, H. Arai, S. Yu, G. B. Mills, R. Tsukahara, N. Makarova, Y. Fujiwara, G. Tigyi, G. D. Prestwich, ChemMedChem 2006, 1, 376-383.
34. "α-Substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA": G. Jiang, Y. Xu, Y. Fujiwara, T. Tsukahara, R. Tsukahara, G. Tigyi, G. D. Prestwich, ChemMedChem 2007, 2, 679-690.
35. "Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors": F. Minutolo, M. Antonello, S. Barontini, S. Bertini, L. Betti, R. Danesi, G. Gervasi, G. Giannaccini, C. Papi, G. Placanic, S. Rapposelli, M. Macchia, Farmaco 2004, 59(11), 887-892.
36. "Acyclic nucleoside phosphonates: a key class of antiviral drugs": E. De Clercq, A. Holy, Nature 2005, 4, 928-940.
37. "5′-O-phosphonomethyl-2′,3′- dideoxynucleosides: synthesis and anti-HIV activity": L. Jie, A. Van Aerschot, J. Balzarini, G. Janssen, R. Busson, J. Hoogmartens, E. De Clercq, P. Hardewijn, J. Med. Chem. 1990, 33(9), 241-245.
38. 3-protecting group": A. Van Aerschot, L. Jie, P. Herdewijn, Tetrahedron Lett. 1991, 32(16), 1905-1908.
39. "Synthesis and molecular recognition of phosphatidylinositol-3- methyl-enephosphate": J. Gajewiak, Y. Xu, S. A. Lee, T. G. Kutateladze, G. D. Prestwich, Org. Lett. 2006, 8, 2811-2813.
40. "Stabilized phosphatidyl-5-phosphate analogues as ligands for the nuclear protein ING2: chemistry, biology, andmolecula r modeling": W. Huang, H. Zhang, F. Davrazou, T. G. Kutateladze, X. Shi, O. Gozani, G. D. Prestwich, J. Am. Chem. Soc. 2007, 129(20), 6498-6506.
41. "Synthesis and biological activity of PTEN-resistant analogues of phosphatidylinositol 3,4,5-trisphosphate": H. Zhang, N. Markadieu, R. Beauwens, C. Erneux, G. D. Prestwich, J. Am. Chem. Soc. 2006, 128, 16464-16465.
42. "Synthesis and reactivity of diethylphosphonomethyl triflate": D. P. Phillion, S. S. Andrew, Tetrahedron Lett. 1986, 27, 1477-1480.
43. "Synthesis of (R)-lysothiophosphatidic acid and (R)-thiophosphatidic acid": N. V. Heeb, K. P. Nambiar, Tetrahedron Lett. 1993, 34(39), 6193-6196.
44. "Synthesis, structure-activity relationships, andthe effect of polyethylene glycol on inhibitors of phosphatidylinositol-specific phospholipase C from Bacillus cereus": M. Ryan, M. P. Smith, T. K. Vinod, W. L. Lau, J. F. W. Keana, O. H. Griffith, J. Med. Chem. 1996, 39(22), 4366-4376.
45. "A new reagent for the removal of the 4-methoxybenzyl ether: application to the synthesis of unusual macrocyclic and bolaform phosphatidylcholines": N. Hebert, A. Beck, R. B. Lennox, G. Just, J. Org. Chem. 1992, 57(6), 1777-1783.
46. J. R. Erickson, Lysophosphatidic acid analogues as agonists of the EDG2 lysophosphatidic acid receptor, US Patent 6,380,177, April 30, 2002.
47. "Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors": T. Virag, D. B. Elrod, K. Liliom, V. M. Sardar, A. L. Parrill, K. Yokoyama, G. Durgam, W. Deng, D. D. Miller, G. Tigyi, Mol. Pharmacol. 2003, 63(5), 1032-1042.
48. "Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma": K. Sheehan, V. Calvert, E. Kay, Y. Lu, D. Fishman, V. Espina, J. Aquino, R. Speer, R. Araujo, G. B. Mills, L. Liotta, E. Petracoin, J. Wulfkuhle, Mol. Cell. Proteomics 2005, 4, 346-355.
49. "Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells": R. Tibes, Y. Qiu, Y. Lu, B. Hennessy, M. Andreeff, G. B. Mills, S. M. Kornblau, Mol. Cancer Ther. 2006, 5(10), 2512-2521.
50. "The energy-sensing LKB1-AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis": J. Liang, S. Shao, Z. Xu, B. Hennessy, Z. Ding, M. Larrea, S. Kondo, D. Dumont, J. U. Gutterman, C. Walker, J. Slingerland, G. B. Mills, Nat. Cell Biol. 2007, 9, 218-224.
51. "Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARγ, and inhibitors of autotaxin": G. G. Durgam, T. Virag, M. Walker, R. Tsukahara, S. Yasuda, K. Liliom, L. van Meeteren, W. H. Moolenaar, N. Wilke, W. Siess, G. Tigyi, D. D. Miller, J. Med. Chem. 2005, 48, 4919-4930.
52. "Autotaxin is overexpressedin glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid": Y. Kishi, S. Okudaira, M. Tanaka, K. Hama, D. Shida, J. Kitayama, T. Yamori, J. Aoki, T. Fujimaki, H. Arai, J. Biol. Chem. 2006, 281(25), 17492-17500.
53. "Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer": H. Yamashita, J. Kitayama, D. Shida, M. Ishikawa, K. Hama, J. Aoki, H. Arai, H. Nagawa, J. Surg. Oncol. 2006, 93, 30-35.
54. "Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells": D. Shida, J. Kitayama, H. Yamaguchi, K. Hama, J. Aoki, H. Arai, H. Yamashita, K. Mori, A. Sako, T. Konishi, T. Watanabe, T. Sakai, R. Suzuki, H. Ohta, Y. Takuwa, H. Nagawa, Exp Cell Res. 2004, 301(2), 168-178.
55. "Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer": D. Shida, T. Watanabe, J. Aoki, K. Hama, J. Kitayama, H. Sonoda, Y. Kishi, H. Yamaguchi, S. Sasaki, A. Sako, T. Konishi, H. Arai, H. Nagawa, Lab. Invest. 2004, 84(10), 1352-1362.
56. "Overexpression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma": J. Kitayama, D. Shida, A. Sako, M. Ishikaa, K. Hama, J. Aoki, H. Arai, H. Nagawa, Breast Cancer Res. 2007, 9, R640-646.
57. 1 (EDG2) in breast carcinoma cells": M. Chen, L. Towers, K. O'Connor, Am. J. Physiol. 2006, 292, C1927-1933.
58. 2 receptor mediates mitogenic signals in human colon cancer cells": C. Yun, H. Sun, D. Wang, R. Rusovici, A. Castleberry, R. Hall, H. Shim, Am. J. Physiol. 2005, 289, C2-11.
59. "Src promotes estrogen-dependent estrogen receptor-α proteolysis in human breast cancer": I. Chu, A. Arnaout, S. Loiseau, J. Sun, A. Seth, C. McMahon, K. Chun, B. Hennessy, G. B. Mills, Z. Nawaz, J. M. Slingerland, J. Clin. Invest. 2007, 117(8), 2205-2215.
60. "A module of negative feedback regulators defines growth factor signaling": I. Amit, A. Citri, T. Shay, Y. Lu, M. Katz, F. Zhang, G. Tarcic, D. Siwak, J. Lahad, J. Jacob-Hirsch, N. Amariglio, N. Vaisman, E. Segal, G. Rechanvi, U. Alon, G. B. Mills, E. Domany, Y. Yarden, Nature Genetics 2007, 39(4), 503-512.